Description
All three antibodies in this combination recognize distinct epitopes in the hydrophilic carboxyl region of the latent membrane protein (LMP) protein encoded by the Epstein Barr Virus antibody (EBV). EBV has been implicated with Hodgkin’s disease, and may be involved in the pathogenesis of Hodgkin’s occurring in children. Other studies have shown a low incidence of EBV in B-cell type lymphomas unless patients were immunologically impaired, such as post-organ transplantation or autoimmune type diseases. Studies have shown that this antibody does stain EBV + Burkitt’s lymphomas but has shown some cross reactivity with smooth muscle and blood vessels.
SPECIFICATIONS
Specifications
WEIGHT | N/A |
---|---|
DIMENSIONS | N/A |
INTENDED USE | ASR |
SPECIES REACTIVITY | Human |
SOURCE | Mouse Monoclonal |
CLONE | EBV01, 02, and 03 |
ISOTYPE | IgG1 /kappa |
ANTIGEN | Epstein-Barr Virus (EBV) protein |
LOCALIZATION | Membrane or paranuclear |
POSITIVE CONTROL | EBV infected Hodgkin’s |
DATASHEETS & SDS
OUS ONLY IVD
REFERENCES
1. Queiroga EM, et al. Am J Clin Pathol. 2008 Aug; 130(2):186-92.
2. Prochorec-Sobieszek M, et al. Pol J Pathol. 2006; 57(2):63-70.
3. Montes-Moreno S, et al. Mod Pathol. 2012 Jul; 25(7):968-82.
Reviews
There are no reviews yet.